| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 137, Issue 12 3900-3908, Copyright © 1986 by American Association of Immunologists
ARTICLES |
S Kure and O Yoshie
We have isolated a syngeneic monoclonal antibody (HepSS-1) reactive to a murine methylcholanthrene-induced fibrosarcoma, Meth-A. HepSS-1 also bound to a wide variety of established and fresh normal cells derived from not only mice but also other species such as human, monkey, rat, hamster, and chicken. Immunoprecipitation of surface iodinated Meth-A cell extract with HepSS-1, as well as Sepharose 4B gel chromatography of Meth-A cell extract and detection of antigens recognized by HepSS-1 by a sandwich-type radioimmunoassay revealed that the HepSS-1 antigens were composed of several molecular species, with one as large as approximately 10(6) daltons. The following evidence indicates that HepSS-1 specifically recognizes an epitope present in heparan sulfate glycosaminoglycan (HS-GAG). First, treatment of Meth-A cells with heparitinase or heparinase, but not with chondroitinase ABC or hyaluronidase, resulted in the loss of HepSS-1 binding. Second, HS-GAG but not seven other types of GAG (hyaluronic acid, heparin, chondroitin, chondroitin 4-sulfate, chondroitin 6-sulfate, dermatan sulfate, and keratan sulfate) inhibited HepSS-1 binding to Meth-A cells. Third, HepSS-1 bound with HS-GAG but not with the seven other types of GAG. From the binding analysis of HepSS-1 to various modified HS-GAG and whale omega-heparin, it is additionally suggested that HepSS- 1 recognizes an epitope closely related to O-sulfated and N-acetylated glucosamine. We found that NIH 3T3 cells expressed more HepSS-1 epitopes at a low cell density than at confluency and in G2 + M than in G1, whereas NIH 3T3 cells transformed with Kirsten-ras oncogene or SV- 40 expressed high levels of HepSS-1 epitopes and ceased to show the density-dependent change in the amount of HepSS-1 epitopes. These observations were also reproduced by using NIH 3T3 cells transformed with a temperature sensitive Kirsten murine sarcoma virus maintained at permissive and non-permissive temperatures. Thus HepSS-1 is a first monoclonal antibody to HS-GAG and seems to be useful to elucidate changes in cell surface HS-GAG in normal cell growth and cell transformation.
This article has been cited by other articles:
|
|
 |
|
  A. Abramsson, S. Kurup, M. Busse, S. Yamada, P. Lindblom, E. Schallmeiner, D. Stenzel, D. Sauvaget, J. Ledin, M. Ringvall, et al. Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development Genes & Dev., February 1, 2007; 21(3): 316 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Warren, A. L. Jones, C. Freeman, J. Bettadapura, and C. R. Parish Evidence That the Cellular Ligand for the Human NK Cell Activation Receptor NKp30 Is Not a Heparan Sulfate Glycosaminoglycan J. Immunol., July 1, 2005; 175(1): 207 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. van den Born, K. Salmivirta, T. Henttinen, N. Ostman, T. Ishimaru, S. Miyaura, K. Yoshida, and M. Salmivirta Novel Heparan Sulfate Structures Revealed by Monoclonal Antibodies J. Biol. Chem., May 27, 2005; 280(21): 20516 - 20523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Ainslie, J. S. Garanich, R. O. Dull, and J. M. Tarbell Vascular smooth muscle cell glycocalyx influences shear stress-mediated contractile response J Appl Physiol, January 1, 2005; 98(1): 242 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yamada, M. Busse, M. Ueno, O. G. Kelly, W. C. Skarnes, K. Sugahara, and M. Kusche-Gullberg Embryonic Fibroblasts with a Gene Trap Mutation in Ext1 Produce Short Heparan Sulfate Chains J. Biol. Chem., July 30, 2004; 279(31): 32134 - 32141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Florian, J. R. Kosky, K. Ainslie, Z. Pang, R. O. Dull, and J. M. Tarbell Heparan Sulfate Proteoglycan Is a Mechanosensor on Endothelial Cells Circ. Res., November 14, 2003; 93 (10): e136 - e142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Frevert, M. G. Kinsella, C. Vathanaprida, R. B. Goodman, D. G. Baskin, A. Proudfoot, T. N. C. Wells, T. N. Wight, and T. R. Martin Binding of Interleukin-8 to Heparan Sulfate and Chondroitin Sulfate in Lung Tissue Am. J. Respir. Cell Mol. Biol., April 1, 2003; 28(4): 464 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kishibe, S. Yamada, Y. Okada, J. Sato, A. Ito, K. Miyazaki, and K. Sugahara Structural Requirements of Heparan Sulfate for the Binding to the Tumor-derived Adhesion Factor/Angiomodulin That Induces Cord-like Structures to ECV-304 Human Carcinoma Cells J. Biol. Chem., May 12, 2000; 275(20): 15321 - 15329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Walz, S McFarlane, Y. Brickman, V Nurcombe, P. Bartlett, and C. Holt Essential role of heparan sulfates in axon navigation and targeting in the developing visual system Development, January 6, 1997; 124(12): 2421 - 2430. [Abstract] [PDF]
|
|
|
|
|
|
Y. Shishido, K. D. Sharma, S. Higashiyama, M. Klagsbrun, and E. Mekada Heparin-like Molecules on the Cell Surface Potentiate Binding of Diphtheria Toxin to the Diphtheria Toxin Receptor/Membrane-anchored Heparin-binding Epidermal Growth Factor-like Growth Factor J. Biol. Chem., December 8, 1995; 270(49): 29578 - 29585. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
